Active, not recruitingPhase 3NCT03892785

MEthotrexate Versus TOcilizumab for Treatment of GIant Cell Arteritis: a Multicenter, Randomized, Controlled Trial

Studying Giant cell arteritis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centre Hospitalier Universitaire Dijon
Intervention
Prednisone treatment(drug)
Enrollment
230 target
Eligibility
50 years · All sexes
Timeline
20202027

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03892785 on ClinicalTrials.gov

Other trials for Giant cell arteritis

Additional recruiting or active studies for the same condition.

See all trials for Giant cell arteritis

← Back to all trials